214 related articles for article (PubMed ID: 2378463)
1. Antigenic structure of Coxiella burnetii. A comparison of lipopolysaccharide and protein antigens as vaccines against Q fever.
Williams JC; Hoover TA; Waag DM; Banerjee-Bhatnagar N; Bolt CR; Scott GH
Ann N Y Acad Sci; 1990; 590():370-80. PubMed ID: 2378463
[TBL] [Abstract][Full Text] [Related]
2. Protective immunity against Q fever induced with a recombinant P1 antigen fused with HspB of Coxiella burnetii.
Li Q; Niu D; Wen B; Chen M; Qiu L; Zhang J
Ann N Y Acad Sci; 2005 Dec; 1063():130-42. PubMed ID: 16481504
[TBL] [Abstract][Full Text] [Related]
3. Antigenic differences between Coxiella burnetii cells revealed by postembedding immunoelectron microscopy and immunoblotting.
McCaul TF; Banerjee-Bhatnagar N; Williams JC
Infect Immun; 1991 Sep; 59(9):3243-53. PubMed ID: 1715326
[TBL] [Abstract][Full Text] [Related]
4. Identification and cloning potentially protective antigens of Coxiella burnetii using sera from mice experimentally infected with Nine Mile phase I.
Zhang GQ; Samuel JE
Ann N Y Acad Sci; 2003 Jun; 990():510-20. PubMed ID: 12860683
[TBL] [Abstract][Full Text] [Related]
5. Identification of Coxiella burnetii CD8+ T-Cell Epitopes and Delivery by Attenuated Listeria monocytogenes as a Vaccine Vector in a C57BL/6 Mouse Model.
Xiong X; Jiao J; Gregory AE; Wang P; Bi Y; Wang X; Jiang Y; Wen B; Portnoy DA; Samuel JE; Chen C
J Infect Dis; 2017 May; 215(10):1580-1589. PubMed ID: 27703037
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of an immunodominant 28-kilodalton Coxiella burnetii outer membrane protein specific to isolates associated with acute disease.
Zhang G; To H; Russell KE; Hendrix LR; Yamaguchi T; Fukushi H; Hirai K; Samuel JE
Infect Immun; 2005 Mar; 73(3):1561-7. PubMed ID: 15731054
[TBL] [Abstract][Full Text] [Related]
7. Chemokine Receptor 7 Is Essential for Coxiella burnetii Whole-Cell Vaccine-Induced Cellular Immunity but Dispensable for Vaccine-Mediated Protective Immunity.
Chen C; van Schaik EJ; Gregory AE; Vigil A; Felgner PL; Hendrix LR; Faris R; Samuel JE
J Infect Dis; 2019 Jul; 220(4):624-634. PubMed ID: 30938819
[TBL] [Abstract][Full Text] [Related]
8. Multivalent vaccines demonstrate immunogenicity and protect against
Jan S; Fratzke AP; Felgner J; Hernandez-Davies JE; Liang L; Nakajima R; Jasinskas A; Supnet M; Jain A; Felgner PL; Davies DH; Gregory AE
Front Immunol; 2023; 14():1192821. PubMed ID: 37533862
[TBL] [Abstract][Full Text] [Related]
9. Humoral immune response to Q fever: enzyme-linked immunosorbent assay antibody response to Coxiella burnetii in experimentally infected guinea pigs.
Williams JC; Thomas LA; Peacock MG
J Clin Microbiol; 1986 Dec; 24(6):935-9. PubMed ID: 3537005
[TBL] [Abstract][Full Text] [Related]
10. Identification and cloning of immunodominant antigens of Coxiella burnetii.
Zhang G; Kiss K; Seshadri R; Hendrix LR; Samuel JE
Infect Immun; 2004 Feb; 72(2):844-52. PubMed ID: 14742528
[TBL] [Abstract][Full Text] [Related]
11. Coxiella burnetii Epitope-Specific T-Cell Responses in Patients with Chronic Q Fever.
Scholzen A; Richard G; Moise L; Hartman E; Bleeker-Rovers CP; Reeves PM; Raju Paul S; Martin WD; De Groot AS; Poznansky MC; Sluder AE; Garritsen A
Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31331958
[TBL] [Abstract][Full Text] [Related]
12. The immune response to phase I and phase II Coxiella burnetii antigens as measured by western immunoblotting.
Blondeau JM; Williams JC; Marrie TJ
Ann N Y Acad Sci; 1990; 590():187-202. PubMed ID: 2378447
[TBL] [Abstract][Full Text] [Related]
13. Immunisation with purified Coxiella burnetii phase I lipopolysaccharide confers partial protection in mice independently of co-administered adenovirus vectored vaccines.
Dold C; Zhu H; Silva-Reyes L; Blackwell L; Linder A; Bewley K; Godwin K; Fotheringham S; Charlton S; Kim YC; Pollard AJ; Rollier CS
Vaccine; 2023 May; 41(19):3047-3057. PubMed ID: 37037709
[TBL] [Abstract][Full Text] [Related]
14. Identification of phase-specific antigenic fractions of Coxiella burnetti by enzyme-linked immunosorbent assay.
Williams JC; Thomas LA; Peacock MG
J Clin Microbiol; 1986 Dec; 24(6):929-34. PubMed ID: 3782458
[TBL] [Abstract][Full Text] [Related]
15. Development of a lipopolysaccharide-targeted peptide mimic vaccine against Q fever.
Peng Y; Zhang Y; Mitchell WJ; Zhang G
J Immunol; 2012 Nov; 189(10):4909-20. PubMed ID: 23053512
[TBL] [Abstract][Full Text] [Related]
16. Protein array of Coxiella burnetii probed with Q fever sera.
Wang X; Xiong X; Graves S; Stenos J; Wen B
Sci China Life Sci; 2013 May; 56(5):453-9. PubMed ID: 23633077
[TBL] [Abstract][Full Text] [Related]
17. Promiscuous
Scholzen A; Richard G; Moise L; Baeten LA; Reeves PM; Martin WD; Brauns TA; Boyle CM; Raju Paul S; Bucala R; Bowen RA; Garritsen A; De Groot AS; Sluder AE; Poznansky MC
Front Immunol; 2019; 10():207. PubMed ID: 30828331
[No Abstract] [Full Text] [Related]
18. Characterization of a phase I Coxiella burnetii chloroform-methanol residue vaccine that induces active immunity against Q fever in C57BL/10 ScN mice.
Williams JC; Damrow TA; Waag DM; Amano K
Infect Immun; 1986 Mar; 51(3):851-8. PubMed ID: 3949384
[TBL] [Abstract][Full Text] [Related]
19. Major Histocompatibility Complex Class II-Restricted, CD4
Ledbetter L; Cherla R; Chambers C; Zhang Y; Mitchell WJ; Zhang G
Infect Immun; 2020 Feb; 88(3):. PubMed ID: 31792078
[TBL] [Abstract][Full Text] [Related]
20. Antigenic analysis for vaccines and diagnostics.
Hendrix LR; Chen C
Adv Exp Med Biol; 2012; 984():299-328. PubMed ID: 22711639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
